Clinical Trials Logo

Filter by:
NCT ID: NCT03829293 Completed - Sedation Clinical Trials

High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation.

ODEPHI
Start date: March 26, 2019
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial comparing high-flow nasal oxygen therapy (HFNO) versus standard oxygen therapy (nasal prongs, nasopharyngeal catheter or standard face mask) during gastrointestinal (GI) endoscopy with sedation to reduce the incidence of hypoxia.

NCT ID: NCT03829072 Completed - Allograft Clinical Trials

Cooking Education and Adapted Physical Activity in Allografted Patients

NUTRITION
Start date: March 21, 2019
Phase: N/A
Study type: Interventional

Majority of patients after allo stem cell transplantation have malnutrition and decrease of physical activities. This state impacts on quality of life and on outcome of some complications like infections, graft versus host disease and could decrease the overall survival. In this study, the investigators propose cooking education and adapted physical activity to improve that. Cooking education and adapted physical activity at home will be performed by two famous chefs for the first one and by a sportive coach for the second every twice week.

NCT ID: NCT03828968 Completed - Urinary Retention Clinical Trials

Chronic Urinary Retention in Elderly Living in Homes for the Aged : Benefits of Bladder Scan Screening

RUC EHPAD
Start date: February 2, 2019
Phase: N/A
Study type: Interventional

The goal of this cross-sectional, multicentric and descriptive epidemiological study is to assess the prevalence of chronic urinary retention (CUR) in elderly living in residential care for dependent elderly people in order to determine if there is an interest in offering them a bladder scan screening.

NCT ID: NCT03828942 Completed - Hematotoxicity Clinical Trials

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

HeMATOX
Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

Several drugs and chemotherapies seem to have an impact on the hematological system. This study investigates reports of hematological toxicities, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

NCT ID: NCT03828747 Completed - Alzheimer's Disease Clinical Trials

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

Start date: January 25, 2019
Phase: Phase 2
Study type: Interventional

This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the clinical efficacy, safety, pharmacokinetics, and pharmacodynamics of semorinemab in patients with moderate AD. The study consists of a screening period, a double-blind treatment period, an optional open-label extension (OLE) period, and a safety follow-up period. There may be up to two study cohorts.

NCT ID: NCT03828552 Completed - Clinical trials for Intensive Care Unit Syndrome

Parents' Experience of Their Children Stay in a Pediatric Intensive Care Unit.

VECUREA
Start date: March 4, 2019
Phase:
Study type: Observational

Children recovered in pediatric intensive care unit (PICU) suffer from severe conditions, sometimes life-threatening. Thus, priority is given to urgent somatic care, children medicalization is strong, invasive technics have to be used, and medical monitoring is close. A stay in PICU often leaves a painful memory to the child and family, and can lead to psychological morbidity such as post-traumatic stress disease. This study aims to assess parents' experience during their child hospitalization in PICU, and the impact of this stay on the entire family in the following month.

NCT ID: NCT03827551 Completed - Parkinson Disease Clinical Trials

Preliminary Study of the Quality of the Oral Flora in Parkinson's Patients

PARKIDENT
Start date: April 29, 2019
Phase: N/A
Study type: Interventional

This is a prospective interventional clinical study whose main objective is to determine the impact of oral hygiene guidance on the oral health status of patients with Parkinson disease

NCT ID: NCT03827252 Completed - Premature Infant Clinical Trials

Respiratory Stability and Vegetative Coupling During Neonatal Skin-to-skin Care

PO-A-PO-PREMA
Start date: September 7, 2018
Phase:
Study type: Observational

The main purpose of this study is to identify and to determine the involvement of cardio-respiratory coordination mechanisms during SSC between the preterm infant and his (her) parent.

NCT ID: NCT03826043 Completed - Neoplasms Clinical Trials

THrombo-Embolic Event in Onco-hematology

THEO
Start date: September 9, 2019
Phase: N/A
Study type: Interventional

The overall incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 1 per 200 cancer patients, about 5 times higher than in the general population. These events are of crucial importance, since nearly 10% of cancer patients died from thromboembolic events (EVT), making them the second leading cause of death in this population. In hospitalized patients, the rate seems to have increase between 1979 and 1990 from 0.6% - 2% before 1990 to 4% since 1990. Thrombotic risk in cancer patients is known and identified. Thrombotic complications affect the survival and quality of life of cancer patients. Chemotherapy is a regular generator of cytopenia, the most prominent of which is thrombocytopenia. In addition, a prospective study of 107 cancer patients in our institution shows that almost 40% of patients over 65 years of age take anticoagulant or antiplatelet therapy. In this specific population (i.e., with cancer and hypocoagulability), the occurrence of thrombosis poses particular problems. The prevalence and incidence of venous thrombosis in this situation is unknown and the behavior to be poorly specified. Based on these considerations, The investigator propose a two-year prospective cohort study to explore the biological parameters of hypocoagulability and to assess the incidence and prevalence of DVT in thrombocytopenic patients on vitamin K antagonists. (AVK), anti-platelet aggregation (AGP) and / or direct oral anticoagulant (AOD). In this study, the investigator means by hypocoagulability any situation modifying the normal coagulation system.

NCT ID: NCT03825679 Completed - Clinical trials for Patient With Symptomatic Cerebral Infarction

Association Between the Composition of the Bacterial Flora of Thrombi and the Etiological Origin of Cerebral Infarction Treated With Thrombectomy

Bacillus
Start date: February 11, 2019
Phase:
Study type: Observational

Cerebral infarction is a major health problem. The two most common causes are atherosclerosis (30 to 35%) and cardio-embolic origin (35 to 40%). However, in 25% of cases the cause is undetermined, known as cryptogenic stroke or stroke of undetermined origin. Paroxysmal Atrial Fibrillation appears to cause a significant proportion of these cryptogenic cerebral infarctions. One of the major challenges in the management of cerebral infarctions is the prevention of recurrence. If the cause is atheromatous, treatment is based on platelet antiaggregants and the correction of cardiovascular risk factors. If the cause is atrial fibrillation, the treatment of choice is anticoagulation therapy. Cryptogenic strokes are managed with antiplatelet therapy. In past studies, the thrombi responsible for cerebral infarctions have been analyzed anatomopathologically to see if the composition of the thrombi could help identify the cause of the cerebral infarction. These studies have proved to be contradictory. The composition of the bacterial flora of cerebral infarct thrombi has not yet been studied, apart from some limited data on septic emboli. In myocardial infarction, the cause of which is almost exclusively atheromatous, bacteria of the periodontal flora have been detected in thrombi of ST-segment elevation infarctions. The causes of cerebral infarction are multiple. The hypotheses explored in this study are that there are differences in the composition of the bacterial flora of the thrombus depending on whether the cause is atheromatous or cardio-embolic and that the study of the composition of the thrombus could be used to identify the cardio-embolic cause in patients with cryptogenic cerebral infarction.